Skip to content
Loop Biz – Lifestyle
Author:
Citius Oncology, Inc.
Citius Oncology Announces Positive Topline Results from Investigator‑Initiated Phase 1 Study of LYMPHIR™ in Combination with Pembrolizumab in Relapsed or Refractory Gynecologic Cancers
March 10, 2026
←
Previous Page
1
2